Evidence·Excretion / Persistence
ReportedClearance evidence
ATLXM0054252
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0054252
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0054252
The effect of hepatic impairment on clearance of lanreotide has not been studied in patients with GEP-NET.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
